Schools; creating the Emerson Kate Cole Act; school medication policies; eliminating references to epinephrine injectors; eliminating reference to certain training program; parent permissions; 911; mandating parent notifications; allergic reactions; model policies; annual training.
HB 2047, the Emerson Kate Cole Act, updates Oklahoma school medication policies to improve safety for students with allergies and asthma. It requires school districts to adopt policies allowing students to self-administer prescribed asthma inhalers, epinephrine for allergic reactions, and cystic fibrosis medications, with written parental permission and physician documentation. Key provisions include mandating annual staff training on recognizing allergic reactions and administering epinephrine, requiring schools to notify parents after medication use, and specifying protocols for stocking and using epinephrine injectors (including 911 contact procedures). The bill also creates model policies for districts to follow and clarifies that schools and staff incur no liability for medication administration under these guidelines. This law, effective May 14, 2025, directly affects public school districts, students with chronic conditions, and their families.
Bill status
signed
all 5 stages cleared
Introduction
Feb 2025
Committee Review
May 2025
House Passage
Mar 2025
Senate Passage
May 2025
Signed into Law
May 2025
Introduced Feb 3, 2025
Signed May 14, 2025
Maddy AI version diff · 4 comparisons
What changed between versions
Floor (House)
→
Floor (Senate)
·
4 edits
MODERATE
The bill was amended to remove references to epinephrine injectors and certain training programs, while modifying policy provisions regarding parent permissions. The core requirements for schools to call 911 when administering epinephrine and notifying parents of allergic reactions remain intact.
Scope change
The bill's scope was narrowed by eliminating references to epinephrine injectors and certain training programs, though the core emergency response requirements remain.
REQUIREMENT
Removed references to epinephrine injectors from the bill text
Eliminated references to certain training programs
Modified policy provisions regarding parent permissions
TECHNICAL
Changed document version from House Floor to Senate Floor version with updated formatting
Floor votes · Senate May 6, 2025 · House Mar 26, 2025
How they voted
47–0
Passed · 2 other
Total votes 49
May 6, 2025
D
Democratic9
100% Yea
R
Republican40
95% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
27
Key actions
7
Committee
6
Amendments
1
May 6, 2025
Committee
Referred for enrollment
lower
May 6, 2025
Upper · Passed
Engrossed measure signed, returned to House
upper
May 6, 2025
Upper · Passed
Measure passed: Ayes: 45 Nays: 0
upper
Apr 15, 2025
Upper · Passed
Reported Do Pass Education committee; CR filed
upper
Mar 27, 2025
Introduced
First Reading
upper
Mar 27, 2025
Lower · Passed
Engrossed, signed, to Senate
lower
Mar 26, 2025
Committee
Referred for engrossment
lower
Mar 26, 2025
Lower · Passed
Third Reading, Measure passed: Ayes: 92 Nays: 0
lower
Mar 26, 2025
Introduced
Amended by floor substitute
lower
Mar 4, 2025
Lower · Passed
CR; Do Pass Education Oversight Committee
lower
Feb 20, 2025
Lower · Passed
Policy recommendation to the Education Oversight committee; Do Pass Common Education
lower
Feb 4, 2025
Committee
Referred to Common Education
lower
Feb 3, 2025
Introduced
First Reading
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2047
Scope: OK
Hi! I can help you understand HB 2047. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline